Amiloride and certain of its derivatives are effective inhibitors of Na/H antiporters and of epithelial Na channels. We describe a simple method for the preparation of a variety of pharmacologically active 6-iodoamiloride derivatives that are labeled with 125I at high specific radioactivity. 6-Dechloroamiloride derivatives (bearing a hydrogen atom instead of the chlorine at the 6 position of the amiloride molecule) are reacted with 125ICl, prepared by the oxidation of the iodide in Na125I preparations. The 125I-labeled derivatives are separated from free 125I by anion exchange chromatography, or purified by thin layer chromatography. Both 6-dechloroamiloride and 5-(N-alkyl)-6-dechloroamiloride derivatives can be labeled by this method, with yields varying between 10 and 70%, depending on the ICl concentration and the structure of the 5-N-alkyl group. Efficient radiolabeling at high specific radioactivity also depends on the use of freshly prepared batches of 125I. Using carrier-free 125I, [125I]6-iodoamiloride and [125I]6-iodo-5-(N-tert-butyl)amiloride were prepared with yields of 27 and 22%, respectively. Potential applications of the 125I-labeled amiloride derivatives include ligand binding and affinity labeling experiments.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0003-2697(88)90090-5DOI Listing

Publication Analysis

Top Keywords

amiloride derivatives
12
derivatives labeled
8
high specific
8
specific radioactivity
8
derivatives
7
preparation 6-125i-labeled
4
amiloride
4
6-125i-labeled amiloride
4
derivatives amiloride
4
derivatives effective
4

Similar Publications

Inflammatory skin disease is characterized by a pathologic interplay between skin cells and immunocytes and can result in disfiguring cutaneous lesions and systemic inflammation. Immunosuppression is commonly used to target the inflammatory component; however, these drugs are often expensive and associated with side effects. To identify previously unidentified targets, we carried out a nonbiased informatics screen to identify drug compounds with an inverse transcriptional signature to keratinocyte inflammatory signals.

View Article and Find Full Text PDF

CARMIL1-AA selectively inhibits macropinocytosis while sparing autophagy.

Mol Biol Cell

January 2025

Department of Developmental and Cell Biology, Charlie Dunlop School of Biological Sciences, University of California, Irvine, CA 92617.

Macropinocytosis is reported to fuel tumor growth and drug resistance by allowing cancer cells to scavenge extracellular macromolecules. However, accurately defining the role of macropinocytosis in cancer depends on our ability to selectively block this process. 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) is widely used to inhibit macropinocytosis but affects multiple Na/H exchangers (NHE) that regulate cytoplasmic and organellar pH.

View Article and Find Full Text PDF
Article Synopsis
  • Lipid-containing vacuoles in microglia have been associated with neurodegenerative disorders for over a century, and recent studies show altered lipid metabolism in these conditions.
  • Research focused on how lipid-enriched nanoparticles affect microglia, revealing that these nanoparticles lead to vacuolization and the formation of Gitterzellen, a distinct microglia phenotype seen in Alzheimer's disease.
  • The study suggests that lipid-nanoparticles trigger this process through specific pathways, providing a valuable in vitro model to investigate the long-term effects of neurodegeneration.
View Article and Find Full Text PDF
Article Synopsis
  • - Cystic fibrosis (CF) is a persistent disease linked to the dysfunctional CFTR protein, which influences immune responses; however, the role of the epithelial sodium channel (ENaC) in CF is not fully understood.
  • - Research found that ENaC is overexpressed in immune cells from CF patients, which contributes to impaired immune functions such as phagocytosis and inflammatory response.
  • - Treatment with Amiloride, an ENaC inhibitor, improved the function of CF macrophages by normalizing oxidative stress production and reducing inflammation, suggesting that targeting ENaC could be beneficial for CF therapies.
View Article and Find Full Text PDF

Arsenic trioxide (ATO) has been shown to inhibit pancreatic cancer (PC) cell growth and to promote the inhibitory effects of gemcitabine (Gem) on PC . However, the high toxicity of ATO associated with the required high doses and indiscriminate targeting has limited its clinical application. This study aimed to determine whether coupling arsenic to a tumor homing peptide would increase the inhibitory potency against PC cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!